Nanogen gets patent for enhancing molecular reactions:
This article was originally published in Clinica
Executive Summary
Molecular and POC diagnostic products maker Nanogen has received a US patent relating to a technology that enables control over a wide range of molecular reactions involved in molecular analyses and diagnostics, including nucleic acid hybridisation and amplification, antibody and antigen reactions. The system described in the patent is at the core of Nanogen's electronic microarray technology, which uses electricity to move and concentrate biological samples in miniature formats for diagnostic applications. It greatly enhances the rate and specificity of the molecular biological reaction, said the San Diego, California firm.